Key facts
- It has raised $970K across 1 recorded rounds; the latest was Seed Round ($850K) in Nov 2021.
- BioSked has filed 2 Form Ds with the SEC since 2022, most recently Sep 2025 ($123K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for BioSked
Funding rounds
1 roundsAbout BioSked
Developer of healthcare scheduling software designed for process optimization in healthcare. The company's software helps in staff schedule management and notification, self-scheduling and shift-swapping, administrative approval, and many others, such as staff hour tracking, overtime, and time-off tracking, robust compliance assurance, and standard time-clocking, enabling radiologists to optimize their schedules.
- Sector
- Healthcare
- HQ
- Rochester, NY, United States
- Founded
- 2021
- Employees
- 17
- Website
- biosked.com/
- Ownership
- Privately Held (backing)
BioSked doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioSked shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioSked in its N-PORT filings yet. We sweep new filings monthly.